300015 爱尔眼科
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.66818.90918.04221.95620.960
总资产报酬率 ROA (%)2.94511.83410.42512.42812.566
投入资产回报率 ROIC (%)3.56114.45513.01615.74213.742

边际利润分析
销售毛利率 (%)48.29350.79350.46351.92351.027
营业利润率 (%)23.73724.29421.94023.29222.449
息税前利润/营业总收入 (%)24.33622.70620.74321.69320.597
净利润/营业总收入 (%)18.71417.95016.69216.46515.758

收益指标分析
经营活动净收益/利润总额(%)97.673115.445118.663127.519139.707
价值变动净收益/利润总额(%)-0.104-0.723-9.385-9.762-9.367
营业外收支净额/利润总额(%)-2.560-8.722-5.980-11.000-13.156

偿债能力分析
流动比率 (X)1.8451.6941.7991.1501.693
速动比率 (X)1.7121.5451.6631.0591.545
资产负债率 (%)32.28433.66333.72444.05231.456
带息债务/全部投入资本 (%)7.2367.5856.72315.026--
股东权益/带息债务 (%)1,060.602999.5261,147.917438.025426.749
股东权益/负债合计 (%)197.299185.555185.995117.504201.576
利息保障倍数 (X)20.41462.811502.14530.57227.156

营运能力分析
应收账款周转天数 (天)34.68230.77634.62435.1840.000
存货周转天数 (天)28.06729.28829.37426.6030.000